Humanetics Corporation is a clinical-stage pharmaceutical company engaged in accelerated discovery, development and commercialization of proprietary drugs in markets with urgent and unmet needs.  With a focus on non-synthetic, self-administered, bioactive compounds for disease prevention and treatment, Humanetics has an extensive patent portfolio and an active pipeline of compounds that range from discovery phase to human clinical trials.  Currently, Humanetics is focused on three biotherapeutic areas with urgent and unmet needs: immunodeficiency disorders, neurodegenerative diseases and metabolic dysfunction.